|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.66 SEK | -0.92% |
|
-6.68% | +18.96% |
| May. 15 | SenzaGen AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
SenzaGen AB reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 14.34 million compared to SEK 12.29 million a year ago. Net loss was SEK 3.06 million compared to SEK 4.91 million a year ago.
Basic loss per share from continuing operations was SEK 0.13 compared to SEK 0.2 a year ago. Diluted loss per share from continuing operations was SEK 0.13 compared to SEK 0.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.96% | 19.88M | |
| -38.56% | 8.39B | |
| +0.18% | 3.32B | |
| +9.29% | 2.49B | |
| -18.21% | 2.06B | |
| -24.57% | 1.59B | |
| +32.37% | 1.15B | |
| -7.64% | 704M | |
| +8.42% | 678M | |
| -29.59% | 508M |
SENZAGEN AB 
